glp 1 ckd GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity Role of GLP-1 Agonists &

Asia Pacific 1

Cant et al

Safety concerns for children and adolescents Hildebrandt said hes concerned that doctors arent adequately warning people about the potential risks of eating disorders before prescribing the medications

1416 Although the safety profile of GLP-1 RAs has generally been acceptable, concerns have arisen regarding a potentially increased risk of thyroid malignancy

During peri-menopausewhen declining oestrogen already increases the risk of osteoporosis and sarcopenia (muscle loss) this reduction can be problematic

Consequently, a significant difference of 16S rRNA microbial profiles was noted between low- and high-TMAO producing status ( p = 0.001, R 2 = 0.027) despite a small effect size (Fig